OCT Compared With IVUS and Angiography to Guide Coronary Stent Implantation (ILUMIEN III: OPTIMIZE PCI)
Ziad A Ali, Akiko Maehara, Philippe Généreux · Randomized controlled trial
BlueRipple Assessment
When a cardiologist places a stent, the question is how well to see what they are doing. Plain angiography shows a silhouette; intravascular imaging shows the artery wall from the inside. This trial pitted two such tools — optical coherence tomography and intravascular ultrasound — against each other and against angiography alone.
Across 450 patients, OCT-guided stenting achieved a final stent expansion that was non-inferior to IVUS guidance. But it was not superior — not to IVUS, and not even convincingly to angiography on the primary measure. The headline was reassurance: OCT, with its very high resolution, is a safe and capable way to optimize a stent, on par with the established ultrasound approach.
The result is meaningful for interventional cardiologists choosing between imaging modalities, but its reach is narrow. It compared a procedural surrogate — how well the stent was expanded — rather than whether patients lived longer or had fewer heart attacks.
We rate the evidence strong as a randomized comparison, with modest clinical significance. It established OCT as a legitimate alternative to IVUS for guiding stent placement, a technical advance rather than a change in who gets treated or why.
The original source
Ali ZA, Maehara A, Généreux P, Shlofmitz RA, Fabbiocchi F, Nazif TM, et al. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial. Lancet. 2016 Nov 26;388(10060):2618-2628.
BlueRipple Health provides consumer education and research synthesis for informed health advocacy. This is not medical advice. Discuss all health decisions with a qualified clinician.